Holen Sie sich die Stockscreener-App
16.85
2.25%
0.37
Handel nachbörslich:
16.50
-0.35
-2.08%
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ ... - Bluefield Daily Telegraph
Lenz, Lunatus announce exclusive partnership for VIZZ in Middle East - Yahoo Finance
LENZ Therapeutics and Lunatus Announce Exclusive Commercialization Partnership for VIZZ in the Middle East - marketscreener.com
LENZ Therapeutics and Lunatus Ink Exclusive Commercialization Partnership for VIZZ in Middle East - VisionMonday.com
Lenz Therapeutics and Lunatus announce partnership for Vizz(TM) - marketscreener.com
FDA-approved presbyopia eye drop VIZZ to reach Middle East - Stock Titan
LENZ Therapeutics responds to FDA adverse event report - MSN
LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year LowWhat's Next? - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc.LENZ - PR Newswire
Is LENZ Therapeutics Inc a good long term investmentConsumer Goods Stocks & Free Stay Informed With Forecasts - earlytimes.in
Aug Mood: Why LENZ Therapeutics Inc stock is recommended by analystsQuarterly Profit Summary & Expert Approved Trade Ideas - moha.gov.vn
LENZ Therapeutics (LENZ) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.1%Time to Sell? - MarketBeat
Lenz plunges after adverse event report on eye therapy - MSN
How LENZ Therapeutics Inc. stock compares to industry benchmarksPortfolio Growth Summary & Growth Focused Investment Plans - Улправда
Is LENZ Therapeutics Inc. stock trading near support levels2025 Institutional Moves & Technical Pattern Recognition Alerts - ulpravda.ru
Why LENZ Therapeutics Inc. stock could outperform in 2025Weekly Trade Analysis & Low Drawdown Investment Ideas - DonanımHaber
How sustainable is LENZ Therapeutics Inc. stock dividend payout2025 Biggest Moves & Technical Entry and Exit Tips - DonanımHaber
Why LENZ Therapeutics Inc. stock is popular among millennialsEarnings Overview Report & Free Weekly Watchlist of Top Performers - Улправда
Hedge Fund Bets: Why LENZ Therapeutics Inc. stock is popular among millennials2025 Analyst Calls & Weekly Setup with High ROI Potential - Улправда
LENZ Therapeutics Stock Plummets 42% With 10-Day Losing Streak - Trefis
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5%What's Next? - MarketBeat
LENZ Therapeutics: Was That A Market Overreaction? (NASDAQ:LENZ) - Seeking Alpha
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
LENZ Therapeutics Stock 9-Day Losing Spree: Stock Falls 40% - Trefis
LENZ Therapeutics Currently Down Nine Consecutive Days, On Pace for Longest Losing Streak Since March 2022 -- Data Talk - 富途牛牛
8-Day Sell-Off Sends LENZ Therapeutics Stock Down 39% - Trefis
LENZ Therapeutics (NASDAQ:LENZ) Shares Gap UpHere's What Happened - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Sees Large Volume IncreaseShould You Buy? - MarketBeat
LENZ Therapeutics Responds to FDA Adverse Event Report - TipRanks
LENZ Therapeutics Addresses Adverse Event Report - TradingView — Track All Markets
Lenz Therapeutics (Nasdaq: LENZ) provides update on VIZZ safety data report - Stock Titan
ABBV Stock News: Lenz Therapeutics Faces Setback with FDA Report - GuruFocus
LENZ stock tumbles after retinal tear case surfaces in FDA database - Investing.com
LENZ stock plunges after adverse event report (LENZ:NASDAQ) - Seeking Alpha
Stempoint Capital LP Buys Shares of 183,912 LENZ Therapeutics, Inc. $LENZ - MarketBeat
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - MSN
LENZ Therapeutics (LENZ) Receives a Buy from Citi - The Globe and Mail
Stock Analysis: Will LENZ Therapeutics Inc stock rally after Fed decisionsWeekly Investment Summary & Long-Term Safe Investment Ideas - BỘ NỘI VỤ
Saturn V Capital Management LP Invests $10.03 Million in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Will LENZ Therapeutics Inc. stock gain from strong economyJuly 2025 Highlights & Smart Swing Trading Alerts - Newser
Transcript : LENZ Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 10 - marketscreener.com
Lenz Therapeutics: A Close Look (NASDAQ:LENZ) - Seeking Alpha
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 6.1%Here's What Happened - MarketBeat
Skandinaviska Enskilda Banken AB publ Acquires New Stake in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Geode Capital Management LLC Grows Stock Position in LENZ Therapeutics, Inc. $LENZ - MarketBeat
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ - Ophthalmology Times
Piper Sandler 37th Annual Healthcare Conference - LENZ Therapeutics
Leadership: Lenz Therapeutics CEO gives people autonomy and responsibility - MSN
Lenz Therapeutics, Lotus Pharmaceutical Say New Drug Application for Presbyopia Treatment Submitted in South Korea - marketscreener.com
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia - The Manila Times
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):